Cloperidone

This classification denotes a sedative and hypnotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8FP5Y6U39R. European Medicines Agency schedules Cloperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06738MIG. Cloperidone generally arises in the molecular formula C21H23CLN4O2. The term CLOPERIDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 no. 12 1967, list 7.) CLOPERIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cloperidone under HS 29335995 and SITC 51576. As of Q4 2014, CLOPERIDONE remains the US FDA Preferred Term for this commodity. Cloperidone bears US NLM identifiers UMLS ID C2699375 and NCI Concept Code C79578. SMILES: CLC1CC(N2CCN(CC2)CCCN2C(=O)C3C([NH]C2=O)CCCC3)CCC1.